Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Loures
Clinical trial register · Portugal

Clinical Trials in Loures, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Portugal and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1104 matching records held by the registry are in this view. Synced 30 Oct 2026, 03:17 UTC
1104
Studies in scope
all four open statuses
533
Recruiting now
open to new participants
285
Lead sponsors
across recruiting studies
Top sites
Lisbon 689 Porto 537 Coimbra 256 Braga 182 Vila Nova de Gaia 105
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AbbVie7 Janssen Research & Development, LLC7 AstraZeneca7 Hoffmann-La Roche6 Bristol-Myers Squibb3
Site location
Lisbon689 Porto537 Coimbra256 Braga182 Vila Nova de Gaia105
All 97 locations
Target enrolment
to

Trials with a site in Loures

67 of 1104 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Portugal
Start
Not yet open
Hugo César Vicente
Not applicable
7
Loures
2027-01
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Vila Nova de Gaia, Lisbon, Loures, Porto
2026-12-16
Recruiting
AbbVie
Phase 3
990
Guimarães, Loures, Almada, Lisbon, Porto
2026-05-22
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Amadora-Lisbon, Lisbon, Loures, Matosinhos Municipality, Porto, Vila Nova de Gaia
2026-05-21
Recruiting
Grifols Therapeutics LLC
Phase 3
40
Guimarães, Loures
2026-05-05
Not yet open
Home Monitoring in eAMD Treatment
NCT07340372Exudative Age-Related Macular Degeneration
DrugAflibercept
Association for Innovation and Biomedical Research on Light and Image
Observational
80
Coimbra, Leiria, Lisbon, Loures, Porto
2026-05
Recruiting
Boehringer Ingelheim
Phase 2
132
Almada, Braga, Lisbon, Loures
2026-03-23
Recruiting
University of Évora
Not applicable
14
Loures
2026-03-02
Recruiting
Boehringer Ingelheim
Phase 3
286
Almada, Amadora, Braga, Coimbra, Lisbon, Loures, Porto, Setúbal
2026-02-16
Recruiting
AbbVie
Phase 2
165
Loures, Senhora da Hora, Faro
2026-01-23
Recruiting
Eikon Therapeutics
Phase 1/2
160
Lisbon, Loures
2026-01-20
Recruiting
AbbVie
Phase 2/3
490
Guimarães, Loures, Senhora da Hora, Braga, Porto
2025-12-10
Recruiting
Hoffmann-La Roche
Phase 3
600
Braga, Loures, Porto, Vila Nova de Gaia
2025-10-24
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Braga, Guimarães, Lisbon, Loures, Porto
2025-10-03
Recruiting
Janssen Research & Development, LLC
Phase 3
882
Braga, Guimarães, Lisbon, Loures, Porto, Viana do Castelo
2025-10-01
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Almada, Baixa Da Banheira, Carnaxide, Coimbra, Creixomil, Leiria, Lisbon, Loures
2025-09-06
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Lisbon, Loures, Matosinhos Municipality
2025-08-26
Recruiting
Association for Innovation and Biomedical Research on Light and Image
Phase 4
120
Coimbra, Leiria, Lisbon, Loures, Porto
2025-08-06
Recruiting
MedSIR
Phase 2
200
Lordelo, Alcabideche, Amadora, Aveiro, Braga, Lisbon, Loures, Porto
2025-06-30
Recruiting
GlaxoSmithKline
Phase 3
981
Loures, Senhora da Hora, Almada, Guarda, Lisbon, Setúbal, Vila Nova de Gaia
2025-06-20
Recruiting
Corxel Pharmaceuticals
Phase 2/3
740
Almada, Braga, Faro, Loures, Matosinhos Municipality
2025-05-15
Recruiting
AstraZeneca
Phase 3
830
Alcabideche, Braga, Coimbra, Lisbon, Loures, Matosinhos Municipality, Porto
2025-04-10
Recruiting
Wissenschaftliches Institut Bethanien e.V
Observational
1,800
Vila Nova de Gaia, Loures
2025-03-24
Active, closed
Immutep S.A.S.
Phase 3
756
Almada, Lisbon, Loures, Porto
2025-03-21
Active, closed
AbbVie
Phase 3
468
Guimarães, Lisbon, Loures, Senhora da Hora, Almada, Aveiro, Braga, Porto
2025-02-10
Recruiting
Janssen Research & Development, LLC
Phase 2
480
Braga, Guimarães, Lisbon, Loures, Porto, Vila Nova de Gaia
2024-12-16
Active, closed
AbbVie
Observational
1,314
Guimarães, Lisbon, Loures, Sintra, Torres Vedras, Coimbra, Porto
2024-11-26
Recruiting
Xencor, Inc.
Phase 1/2
270
Loures
2024-10-10
Recruiting
Stemline Therapeutics, Inc.
Phase 3
4,220
Loures, Vila Franca de Xira, Porto, Vila Nova de Gaia, Coimbra, Faro, Lisbon, Setúbal
2024-09-27
Recruiting
Janssen Research & Development, LLC
Phase 3
752
Braga, Leiria, Lisbon, Loures, Ponta Delgada, Porto, Touguinho
2024-07-25
Recruiting
Eli Lilly and Company
Phase 3
510
Almada, Aveiro, Braga, Loures, Seco Portimao Faro, Senhora da Hora
2024-04-29
Recruiting
CSL Behring
Phase 2/3
3,110
Braga, Canelas-V.N.Gaia, Carregado, Faro, Lisbon, Loures, Oeiras, Porto
2024-04-27
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Braga, Lisbon, Loures, Porto, Vila Nova de Gaia
2023-10-25
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Alcabideche, Lisboa, Amadora, Lisboa, Braga, Lisbon, Loures, Porto, Vila Real
2023-10-24
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Faro, Lisbon, Loures, Porto, Vila Nova de Gaia
2023-09-14
Active, closed
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
NCT05587296Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
Bayer
Phase 3
474
Loures, Braga, Coimbra, Lisbon, Porto
2022-10-14
Recruiting
EMD Serono Research & Development Institute, Inc.
Observational
700
Loures, Lisbon, Porto, Porto Covo
2022-10-04
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Lisbon, Loures, Portimão, Santa Maria da Feira, Vila Nova de Gaia
2022-09-19
Active, closed
AbbVie
Observational
785
Funchal, Almada, Faro, Lisbon, Loures, Porto, Viseu
2022-08-15
Recruiting
Ionis Pharmaceuticals, Inc.
Phase 1
40
Loures
2022-07-21
Active, closed
Hoffmann-La Roche
Phase 3
922
Coimbra, Lisbon, Loures, Porto
2022-07-18
Active, closed
Novartis Pharmaceuticals
Phase 4
134
Lisbon, Loures, Porto
2022-07-07
Recruiting
Dimerix Bioscience Pty Ltd
Phase 3
286
Braga, Carnaxide, Lisbon, Loures, Porto, Setúbal, Vila Franca de Xira, Vila Nova de Gaia
2022-05-30
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 2/3
522
Amadora, Lisbon, Loures
2022-03-30
Active, closed
AstraZeneca
Phase 3
1,051
Lisbon, Loures, Porto
2022-02-07
Active, closed
Janssen Research & Development, LLC
Phase 3
776
Lisbon, Loures, Porto
2021-11-17
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Lisbon, Vila Nova de Gaia, Guimarães, Loures, Porto, Vila Real
2021-08-27
Active, closed
GLSMED Learning Health S.A.
Not applicable
533
Almada, Lisbon, Loures
2021-08-01
Active, closed
AstraZeneca
Phase 3
315
Guimarães, Lisbon, Loures, Porto, Vila Nova de Gaia
2021-06-30
Active, closed
GlaxoSmithKline
Phase 3
40
Lisbon, Loures
2021-06-28
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Lisbon, Loures, Porto
2021-05-04
Recruiting
Ipsen
Phase 1/2
240
Guimarães, Loures, Matosinhos Municipality, Viana do Castelo
2021-04-29
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Almada, Braga, Coimbra, Guimarães, Lisbon, Loures, Porto, Santa Maria da Feira
2021-02-23
Active, closed
AstraZeneca
Phase 3
1,371
Braga, Guimarães, Lisbon, Loures, Porto, Vila Nova de Gaia
2021-01-28
Active, closed
Janssen Research & Development, LLC
Phase 2
220
Almada, Aveiro, Guimarães, Lisbon, Loures, Porto, Vila Nova de Gaia, Vila Real
2020-12-18
Active, closed
Daiichi Sankyo
Phase 3
1,600
Guimarães, Lisbon, Loures, Matosinhos Municipality, Porto, Vila Nova de Gaia
2020-12-04
Active, closed
Exelixis
Phase 3
575
Braga, Guimarães, Lisbon, Loures, Porto, Vila Real
2020-10-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
520
Loures, Coimbra, Lisbon
2020-05-19
Active, closed
Biogen
Phase 3
152
Lisbon, Loures, Braga, Coimbra, Porto
2019-10-18
Active, closed
Hoffmann-La Roche
Phase 3
1,013
Loures, Almada, Braga, Porto, Torres Vedras
2019-08-12
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Almada, Coimbra, Lisbon, Loures, Porto
2019-03-21
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Braga, Coimbra, Lisbon, Loures, Matosinhos Municipality, Porto, Santa Maria da Feira
2018-12-28
Active, closed
AbbVie
Phase 3
1,336
Guimarães, Portimão, Lisbon, Santa Maria DA Feira, Almada, Faro, Loures, Porto
2018-04-09
Active, closed
AstraZeneca
Phase 2
273
Lisbon, Loures, Porto, Vila Nova de Gaia
2018-03-07
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
518
Lisbon, Loures, Porto
2017-06-21
Active, closed
AstraZeneca
Phase 3
1,126
Lisbon, Loures, Porto
2015-11-02
Active, closed
AstraZeneca
Phase 3
1,837
Lisbon, Loures, Porto
2014-04-22
Rows per page Showing 1–67 of 67
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Portuguese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 2 November 2026. https://priyalifescience.com/clinical-trials-portugal/city/loures

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Portugal and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,104 studies in total at the last sync on 30 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 67 of those studies with a site in Loures.

How many clinical trials are recruiting in Loures?

31 of the 67 studies on this page are recruiting new participants as of the 30 Oct 2026, 03:17 UTC sync. A further 3 have not yet opened recruitment, 33 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Loures), 67 studies
PhaseStudiesRecruitingShare
Phase 3391358.2%
Phase 27410.4%
Observational639%
Phase 2/3659%
Not applicable314.5%
Phase 1/2334.5%
Phase 4213%
Phase 1111.5%

Most active sponsors

Lead sponsors with the most studies (Loures)
Lead sponsorStudiesRecruiting
AbbVie73
AstraZeneca71
Janssen Research & Development, LLC74
Hoffmann-La Roche62
Bristol-Myers Squibb30
Association for Innovation and Biomedical Research on Light and Image21
Boehringer Ingelheim22
GlaxoSmithKline21
Novartis Pharmaceuticals20
Alliance Foundation Trials, LLC.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.